GREY:ATTBF - Post Discussion
Post by
fasttrack5 on May 21, 2019 8:32pm
ATT
NewsLetter from Abattis | Abattis Newsletter Relaunch!
We are happy to announce that we are relaunching the Abattis newsletter in order to stay better connected with our shareholders, complement our news releases and provide cannabis industry highlights as they pertain to the Company.
In this issue of the newsletter, we discuss recent acquisitions, operational updates, management changes as well FAQs.
The Company would like to offer our sincerest gratitude to our stakeholders for their ongoing patience and support in the face of the prolonged cease trade order, brought due to the delay in filing our audited financial statements. During this period we have continued to receive overwhelming support from our loyal shareholders and stakeholders and will continue to work tirelessly to remedy the situation. We hope to be trading again as soon as possible.
We thank you for subscribing to our newsletter and hope you find the information both relevant and informative. If you do not wish to receive this newsletter in the future, please unsubscribe below.
Our shareholders are our top priority and we thank you for your support. | |
| Acquisition of European
Distribution Company | |
On March 27, 2019, our wholly-owned subsidiary entered into a definitive agreement to acquire European-based nutraceutical company, Pro Natura B.V. As announced by our press release today, we have now completed this acquisition.
Pro Natura has over 30 years of nutraceutical operations and sales experience in Europe, with over 100 products that have been marketed to both long-term repeat customers and new large groups of distributors. Pro Natura has also been supported by a seasoned management team that still includes its original founder and has historically boasted €10M+ per annum in sales.
According to a recent BCC Research Market Report, the global nutraceuticals market is projected to reach US$336.1 billion by 2023 from US$230.9 billion in 2018, growing at a CAGR of 7.8% during the forecast period. As noted in a recent Brightfield Group Report, the market for CBD in Europe alone is projected to exceed €1.2 billion by 2023, growing over 400% from the market’s estimated value of €318 million in 2018.
Through Pro Natura, we hope to gain a distribution network through which to sell CBD products, as we introduce such products to the market through our wholly-owned subsidiary, Vergence Naturals. | |
Be the first to comment on this post